STOCK TITAN

Strata Critical Medical Stock Price, News & Analysis

SRTAW NASDAQ

Company Description

Strata Critical Medical (NASDAQ: SRTAW) is a publicly traded company in the Services-health Services sector.

SRTAW stock has declined 93.8% over the past year. Shares last traded at $0.0126.

On a trailing twelve-month basis, Strata Critical Medical reported revenue of $197.1M with net income of $41.3M and diluted earnings per share of $0.50. The company operates at a net profit margin of 21.0%.

This page provides a comprehensive overview of SRTAW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$0.0124
-1.64%
0.00
Last updated: April 9, 2026 at 14:47
-93.8%
Performance 1 year

Strata Critical Medical (SRTAW) stock last traded at $0.0126, down 1.64% from the previous close. Over the past 12 months, the stock has lost 93.8%.

Latest News

No recent news available for SRTAW.

SEC Filings

Strata Critical Medical has filed 5 recent SEC filings, including 1 Form 4, 1 Form SCHEDULE 13D/A, 1 Form SCHEDULE 13D, 1 Form 4/A. The most recent filing was submitted on April 8, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SRTAW SEC filings →

Financial Highlights

Strata Critical Medical generated $197.1M in revenue over the trailing twelve months, retaining a 20.9% gross margin, operating income reached -$22.4M (-11.3% operating margin), and net income was $41.3M, reflecting a 21.0% net profit margin. Diluted earnings per share stood at $0.50. The company generated -$48.9M in operating cash flow. With a current ratio of 6.38, the balance sheet reflects a strong liquidity position.

$197.1M
Revenue (TTM)
$41.3M
Net Income (TTM)
-$48.9M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Strata Critical Medical (SRTAW) currently stands at 22.5 thousand shares, up 57.9% from the previous reporting period, representing 0.2% of the float. Over the past 12 months, short interest has increased by 243.4%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months

Days to cover for Strata Critical Medical (SRTAW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.

SRTAW Company Profile & Sector Positioning

Strata Critical Medical (SRTAW) operates in the Services-health Services sector and is listed on the NASDAQ.

Frequently Asked Questions

What is the current stock price of Strata Critical Medical (SRTAW)?

The current stock price of Strata Critical Medical (SRTAW) is $0.0126 as of April 8, 2026.

What is the revenue (TTM) of Strata Critical Medical (SRTAW) stock?

The trailing twelve months (TTM) revenue of Strata Critical Medical (SRTAW) is $197.1M.

What is the net income of Strata Critical Medical (SRTAW)?

The trailing twelve months (TTM) net income of Strata Critical Medical (SRTAW) is $41.3M.

What is the earnings per share (EPS) of Strata Critical Medical (SRTAW)?

The diluted earnings per share (EPS) of Strata Critical Medical (SRTAW) is $0.50 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Strata Critical Medical (SRTAW)?

The operating cash flow of Strata Critical Medical (SRTAW) is -$48.9M. Learn about cash flow.

What is the profit margin of Strata Critical Medical (SRTAW)?

The net profit margin of Strata Critical Medical (SRTAW) is 21.0%. Learn about profit margins.

What is the operating margin of Strata Critical Medical (SRTAW)?

The operating profit margin of Strata Critical Medical (SRTAW) is -11.3%. Learn about operating margins.

What is the gross margin of Strata Critical Medical (SRTAW)?

The gross profit margin of Strata Critical Medical (SRTAW) is 20.9%. Learn about gross margins.

What is the current ratio of Strata Critical Medical (SRTAW)?

The current ratio of Strata Critical Medical (SRTAW) is 6.38, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Strata Critical Medical (SRTAW)?

The gross profit of Strata Critical Medical (SRTAW) is $41.1M on a trailing twelve months (TTM) basis.

What is the operating income of Strata Critical Medical (SRTAW)?

The operating income of Strata Critical Medical (SRTAW) is -$22.4M. Learn about operating income.